Didanosine - Bristol-Myers Squibb
Alternative Names: BMY-40900; ddI; deoxyinosine; Megavir; Ronvir; VidexLatest Information Update: 05 Nov 2023
At a glance
- Originator Bristol-Myers Squibb
- Class Antiprotozoals; Antiretrovirals; Dideoxynucleosides; Purine nucleosides; Ribonucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed HIV infections
- Discontinued Toxoplasmosis